Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-20

FDA Approved: ZESTORETIC — Supplemental Application (Almatica Pharma Inc.)

View source ↗

Summary

The FDA granted approval of a supplemental application for ZESTORETIC (lisinopril/hydrochlorothiazide) submitted by Almatica Pharma Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZESTORETIC (LISINOPRIL AND HYDROCHLOROTHIAZIDE)

Snippet

SUPPL AP for ZESTORETIC (LISINOPRIL AND HYDROCHLOROTHIAZIDE)